Moon Jeong Lee1, Jennifer A Deal2,3, Pradeep Y Ramulu1, A Richey Sharrett4,5, Alison G Abraham1,2. 1. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Department of Epidemiology, The Johns Hopkins Medical Institutions, Baltimore, Maryland. 3. The Johns Hopkins Cochlear Center for Hearing and Public Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 4. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 5. Division of Cardiovascular Disease and Clinical Epidemiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abstract
OBJECTIVE: To determine the prevalence of retinal microvascular signs and associations between retinal signs and cognitive status. DESIGN: Cross-sectional analysis of visit 5 (2011-2013) of the Atherosclerosis Risk in Communities (ARIC) cohort. Data analysis took place November 30, 2017, to May 1, 2018. SETTING: Biracial population-based cohort from four US communities. PARTICIPANTS: A total of 2624 participants with a mean age of 76 years (SD = 5 years) (19% African American) with data on cognitive status and complete retinal examination. MEASUREMENTS: Retinal signs measured with fundus photography. Cognitive status: normal cognition, mild cognitive impairment (MCI)/dementia with a primary diagnosis of Alzheimer disease (AD) without cerebrovascular disease (CVD), and MCI/dementia with a primary or secondary diagnosis of CVD (irrespective of AD). RESULTS: Overall, 6% of the cohort had mild retinopathy and 2% had moderate/severe retinopathy. Of the cohort, 7% had microaneurysms, 6% had retinal hemorrhages, and 8% had arteriovenous (AV) nicking. There was a low prevalence of soft exudates (1%) and focal narrowing (1%). In weighted fully adjusted models, individuals with retinal hemorrhages had a two-fold higher odds of all-cause MCI/dementia (95% confidence interval [CI] = 1.3-3.0; P = .001) and a 2.5-fold higher odds (95% CI = 1.6-3.9; P < .001) of MCI/dementia with CVD compared to individuals with no retinal hemorrhages. Individuals with AV nicking had a 1.6-fold higher odds of MCI/dementia with CVD (95% CI = 1.0-2.4) compared to individuals with no AV nicking (P < .05). There were no associations between retinal signs and MCI/dementia without CVD. CONCLUSION: Our findings are confirmatory of recent research, and suggest that retinal microvascular signs may reflect microvascular pathology in the brain, potentially contributing to dementia and earlier MCI. The low prevalence of retinal signs and modest associations with cognitive status, however, limit the current clinical utility of these findings. Further work is needed to determine whether more sophisticated imaging may detect more subtle retinal signs with higher sensitivity to identify individuals at risk of dementia.
OBJECTIVE: To determine the prevalence of retinal microvascular signs and associations between retinal signs and cognitive status. DESIGN: Cross-sectional analysis of visit 5 (2011-2013) of the Atherosclerosis Risk in Communities (ARIC) cohort. Data analysis took place November 30, 2017, to May 1, 2018. SETTING: Biracial population-based cohort from four US communities. PARTICIPANTS: A total of 2624 participants with a mean age of 76 years (SD = 5 years) (19% African American) with data on cognitive status and complete retinal examination. MEASUREMENTS: Retinal signs measured with fundus photography. Cognitive status: normal cognition, mild cognitive impairment (MCI)/dementia with a primary diagnosis of Alzheimer disease (AD) without cerebrovascular disease (CVD), and MCI/dementia with a primary or secondary diagnosis of CVD (irrespective of AD). RESULTS: Overall, 6% of the cohort had mild retinopathy and 2% had moderate/severe retinopathy. Of the cohort, 7% had microaneurysms, 6% had retinal hemorrhages, and 8% had arteriovenous (AV) nicking. There was a low prevalence of soft exudates (1%) and focal narrowing (1%). In weighted fully adjusted models, individuals with retinal hemorrhages had a two-fold higher odds of all-cause MCI/dementia (95% confidence interval [CI] = 1.3-3.0; P = .001) and a 2.5-fold higher odds (95% CI = 1.6-3.9; P < .001) of MCI/dementia with CVD compared to individuals with no retinal hemorrhages. Individuals with AV nicking had a 1.6-fold higher odds of MCI/dementia with CVD (95% CI = 1.0-2.4) compared to individuals with no AV nicking (P < .05). There were no associations between retinal signs and MCI/dementia without CVD. CONCLUSION: Our findings are confirmatory of recent research, and suggest that retinal microvascular signs may reflect microvascular pathology in the brain, potentially contributing to dementia and earlier MCI. The low prevalence of retinal signs and modest associations with cognitive status, however, limit the current clinical utility of these findings. Further work is needed to determine whether more sophisticated imaging may detect more subtle retinal signs with higher sensitivity to identify individuals at risk of dementia.
Authors: Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps Journal: Alzheimers Dement Date: 2011-04-21 Impact factor: 21.566
Authors: Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps Journal: Alzheimers Dement Date: 2011-04-21 Impact factor: 21.566
Authors: L D Hubbard; R J Brothers; W N King; L X Clegg; R Klein; L S Cooper; A R Sharrett; M D Davis; J Cai Journal: Ophthalmology Date: 1999-12 Impact factor: 12.079
Authors: Lawton S Cooper; Tien Y Wong; Ronald Klein; A Richey Sharrett; R Nick Bryan; Larry D Hubbard; David J Couper; Gerardo Heiss; Paul D Sorlie Journal: Stroke Date: 2005-11-23 Impact factor: 7.914
Authors: Ning Cheung; Thomas Mosley; Amirul Islam; Ryo Kawasaki; A Richey Sharrett; Ronald Klein; Laura H Coker; David S Knopman; Dean K Shibata; Diane Catellier; Tien Y Wong Journal: Brain Date: 2010-06-02 Impact factor: 13.501
Authors: A Alonso; T H Mosley; R F Gottesman; D Catellier; A R Sharrett; J Coresh Journal: J Neurol Neurosurg Psychiatry Date: 2009-08-19 Impact factor: 10.154
Authors: S R Lesage; T H Mosley; T Y Wong; M Szklo; D Knopman; D J Catellier; S R Cole; R Klein; J Coresh; L H Coker; A R Sharrett Journal: Neurology Date: 2009-09-15 Impact factor: 9.910
Authors: Tien Yin Wong; Ronald Klein; A Richey Sharrett; F Javier Nieto; Lori L Boland; David J Couper; Thomas H Mosley; Barbara E K Klein; Larry D Hubbard; Moyses Szklo Journal: Stroke Date: 2002-06 Impact factor: 7.914
Authors: Phillip H Hwang; Will T Longstreth; Stephen M Thielke; Courtney E Francis; Marco Carone; Lewis H Kuller; Annette L Fitzpatrick Journal: Alzheimers Dement Date: 2021-03-31 Impact factor: 21.566
Authors: Alison G Abraham; Xinxing Guo; Lubaina T Arsiwala; Yanan Dong; A Richey Sharrett; David Huang; Qisheng You; Liang Liu; Brandon J Lujan; Alexander Tomlinson; Thomas Mosley; Josef Coresh; Yali Jia; Aleksandra Mihailovic; Pradeep Y Ramulu Journal: J Am Geriatr Soc Date: 2021-05-19 Impact factor: 7.538